This week, several major companies are making significant corporate moves that could impact investors. From bonus issues and stock splits to dividend payouts, it’s important to stay informed about these actions and how they affect your portfolio and investment strategy.
Company Name | Corporate Action | Details | Record Date |
Wipro | Bonus Issue | 1:1 bonus issue announced | December 3, 2024 |
Diamond Power Infrastructure | Stock Split | Split 1 share with a face value of ₹10 into 10 shares of face value ₹1. | December 3, 2024 |
Can Fin Homes | Interim Dividend | Interim dividend of ₹6 per share. | December 4, 2024 |
Eraaya Lifespaces | Stock Split | Split 1 share with a face value of ₹10 into 10 shares of face value ₹1. | December 6, 2024 |
Strides Pharma Science | Business Spin-Off | Spin-off of its OneSource business. Eligible shareholders will receive shares in OneSource. | December 6, 2024 |
To be eligible for Wipro’s 1:1 bonus issue, investors must purchase shares before December 3, 2024. This is the last day to buy shares to receive the bonus, which will be issued on a 1:1 basis for every share held by eligible shareholders.
Diamond Power Infrastructure is splitting its shares at a ratio of 1:10, with each ₹10 face value share being converted into 10 shares of ₹1 face value. To be eligible for this stock split, investors must hold shares before the record date of December 3, 2024.
Can Fin Homes, a subsidiary of Canara Bank, has declared an interim dividend of ₹6 per share. To receive this dividend, investors must hold shares of the company before the record date of December 4, 2024, ensuring they are eligible for the payout.
Eraaya Lifespaces is splitting its shares at a 1:10 ratio, where each ₹10 face value share will be split into 10 shares of ₹1 face value. To benefit from this stock split, investors must hold shares before the record date of December 6, 2024.
Strides Pharma Science will be spinning off its OneSource business, distributing shares of the newly created entity to eligible shareholders. To be eligible for this spin-off, investors must hold Strides Pharma shares before December 6, 2024.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.
We're Live on WhatsApp! Join our channel for market insights & updates